Opium as a risk factor for upper gastrointestinal cancers: A population-based case-control study in Iran

Archives of Iranian Medicine

Volumn 17, Issue 1, 2014, Pages 2-6

  Naghibzadeh Tahami, Ahmad ^a,b   Khanjani, Narges ^c   Yazdi Feyzabadi, Vahid ^d,e   Varzandeh, Masoomeh ^f   Haghdoost, Ali Akbar ^g  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Case control; Iran; Opium; Risk factors; UGI neoplasms

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; INCIDENCE; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; RISK FACTOR; STRUCTURED QUESTIONNAIRE;

AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOOD HABITS; HUMANS; IRAN; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OPIOID-RELATED DISORDERS; OPIUM; PANCREATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 84893044189     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. Cancer J Clin. 2002; 55: 74-108.
2. th ed. World Health Organization. 2000: 43-45.
3. Mousavi S, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancerincidence and mortality in Iran. Annals of Oncology Advance Access. 2008.
4. Haghighi P, Nasar K. Gastrointestinal cancer in Iran. J Chronic Dis. 1971; 24: 625-633.
5. Bagnardi A, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. British Journal of Cancer. 2001; 85: 1700-1705.
6. Marjani H, Biramijamal F, Hossein-Nezhad A, Islami F, Pourshmas A, Semnani S. Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high Incidence area in Iran. Arch Iran Med. 2010; 13 (2): 111-115.
7. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. British Journal of Cancer. 2004; 90: 1402-1406.
8. Sadjadi A, Zahedi MJ, Darvish Moghadam S, Nouraie M, Alimohammadian M, Ghorban Bahmanyar S, et al. The First Population-Based Cancer Survey in Kerman Province of Iran. Iranian J Publ Health. 2007; 36: 26-34.
9. Darvish Moghaddam S, Haghdoost A, Hoseini SY, Ramazani R, Rezazadeh Kermani M. Incidence of hepatocellular carcinoma in southeast of Iran. Hepat Mon. 2010; 10(4): 270-274.
10. Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. Opium consumption and risk of bladder cancer: A case-control analysis. Urol Oncol-Semin Ori. 2010; 28: 610-616.
11. Sadeghi A, Behmard S, Vesselinovitch SD. Opium: a potential urinary bladder carcinogen in man. Cancer. 1979; 43: 2315-2321.
12. Mousavi MR, Damghani MA, Haghdoust AA, Khamesipour A. Opium and risk of laryngeal cancer. Laryngoscope. 2003; 113: 1939-1943.
13. Masjedi MR, Naghan PA, Taslimi S, Yousefifard M. Ebrahimi SM, Khosravi A, et al. Opium could be considered an independent risk factor for lung cancer: A case-control study. Respiration. 2013; 85(2): 112-118.
14. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Brit J Cancer. 2008; 98: 1857-1863.
15. Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, Islami F, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One. 2012; 7: 32711.
16. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium; an emerging riskfactor for gastric adenocarcinoma. International Journal of Cancer. 2013; 2: 455-461.
17. Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, et al. Neglected role of hookah and opium in gastric carcinogenesis: A cohort study on risk factors and attributable fractions. International Journal of Cancer. 2014; 1;134(1): 181-188.
18. Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. Journal of Applied Sciences. 2005; 5(2): 380-382.
19. Nakhaee N, Divsalar K, Meimandi M, Dabiri S. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Substance use & misuse. 2008; 43: 513-520.
20. Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, et al. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilotphase of Golestan cohort study of esophageal cancer. European Journal of Clinical Nutritio. 2006; 60: 971-977.
21. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, et al. Reliability and validity of opiate use self-report in a populationat high risk for esophageal cancer in Golestan, Iran. Cancer Epidem Biomar. 2004;13: 1068-1070.
22. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Increased mortality from opium use in the Golestan cohort study: A prospective cohort study of 50,000 Adults. BMJ. 2012; 344: 1-12.
23. Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Cabral JR, et al. Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res. 1985; 150: 177-191.
24. Hewer T, Rose E, Ghadirian P, Castegnaro M, Malaveille C, Bartsch H. Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet. 1978; 2: 494-496.
25. Perry PE, Thomson EJ, Vijayalaxmi, Evans HJ, Day NE, Bartsch H. Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis. 1983; 4: 227-230.
26. Aghaee-Afshar M, Khazaeli P, Behnam B, Zadehkermani M, Ashraf-Ganjooei N. Presence of Lead in Opium. Arch Iranian Med. 2008; 11(5): 553-554.
27. Salehi H, Sayadi A, Tashakori M, Yazdandoost R, Soltanpoor N, Sadeghi H, et al. Comparison of serum lead level in oral opium addicts with healthy control group. Arch Iranian Med. 2009; 12(6): 555-558.
28. Amiri M, Amini R. A comparison of blood-lead level (BLL) in opium-dependant addicts with healthy control group using the graphite furnace/atomic absorption spectroscopy (GF-AAS) followed by chemometric analysis. Iran Red Crescent Med J. 2012; 14(8): 488-491.
29. Tramacere I, La Vecchia C, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology. 2011; 22: 344-349.
30. Talamini R, Polesel J, Gallus S, Maso Da, Zucchetto A, Negri E, et al. Tobacco smoking, alcohol consumption and pancreatic cancerrisk: A case-control study in Italy, European Journal Of Cancer. 2010; 46: 370-376.
31. Pourshams A, Saadatian-Elahi M, Nouraie M, Fazeltabar A, Rakhshani N, Salahi R. Golestan cohort study of esophageal cancer: feasibility and first results. Br J Cancer 2004; 92: 176-181.